The Added Value of Vessel Wall MRI in the Detection of Intraluminal Thrombus in Patients Suspected of Craniocervical Artery Dissection.
Craniocervical Artery Dissection
DSA
Thrombus
Vessel Wall MRI
Journal
Aging and disease
ISSN: 2152-5250
Titre abrégé: Aging Dis
Pays: United States
ID NLM: 101540533
Informations de publication
Date de publication:
Dec 2021
Dec 2021
Historique:
received:
11
11
2020
accepted:
02
05
2021
entrez:
9
12
2021
pubmed:
10
12
2021
medline:
10
12
2021
Statut:
epublish
Résumé
Patients with craniocervical artery dissection (CCAD) have a high short-term risk of ischemic stroke, which is frequently associated with thromboembolism. Previous studies have demonstrated the utility of three-dimensional vessel wall MR imaging (3D-VWMRI) in the diagnosis of dissection. Few have investigated the value of 3D-VWMRI in the detection of intraluminal thrombus. The purpose of the current study was to evaluate the added value of 3D-VWMRI for thrombus identification in patients suspected of CCAD. One hundred and four patients (mean age, 44.2 years ± 13.2) suspected of CCAD and scheduled for digital subtraction angiography (DSA) were prospectively enrolled in the study and underwent VWMRI examination. The diagnostic performance of 3D-VWMRI for CCAD was evaluated using receiver operating characteristic (ROC) analysis with the final diagnosis results as the reference. The presence/absence of intraluminal thrombus on 3D-VWMRI/DSA was independently determined. The sensitivity and specificity of 3D-VWMRI for intraluminal thrombus detection were assessed with DSA serving as the reference. The odds ratio (OR) was used to evaluate the correlation between thrombus presented on 3D-VWMRI/DSA and ischemic stroke. The 3D-VWMRI had high sensitivity (90.0%) and specificity (94.3%) in identifying arteries with CCAD. The area under the ROC curve was 0.96. With DSA as the reference, the sensitivity and accuracy of 3D-VWMRI for the detection of intraluminal thrombus were 97.4% and 79.0%, respectively. An intraluminal thrombus present on 3D-VWMRI was strongly associated with a territorial ischemic stroke (OR: 30.0; 95% confidence interval: 9.1-98.4;
Identifiants
pubmed: 34881091
doi: 10.14336/AD.2021.0502
pii: ad-12-8-2140
pmc: PMC8612619
doi:
Types de publication
Journal Article
Langues
eng
Pagination
2140-2150Informations de copyright
Copyright: © 2021 Liu et al.
Déclaration de conflit d'intérêts
Conflicts of interest The authors disclose no potential conflicts of interest.
Références
Biochem Med (Zagreb). 2012;22(3):276-82
pubmed: 23092060
Curr Med Imaging Rev. 2018 Apr;14(2):207-222
pubmed: 29853818
Stroke. 2014 Oct;45(10):3155-74
pubmed: 25104849
Eur Neurol. 2009;62(2):72-8
pubmed: 19521081
Radiographics. 2008 Oct;28(6):1711-28
pubmed: 18936031
Stroke. 2012 May;43(5):1354-61
pubmed: 22403053
J Neurosurg. 2000 Jul;93(1):19-25
pubmed: 10883900
World Neurosurg. 2018 Apr;112:186-198
pubmed: 29360586
AJNR Am J Neuroradiol. 2020 Mar;41(3):380-386
pubmed: 32029468
Neurology. 2020 Jan 14;94(2):e170-e180
pubmed: 31757869
Radiology. 2018 Jan;286(1):12-28
pubmed: 29261469
BMJ. 2013 Oct 25;347:f5605
pubmed: 24162938
J Neurol Neurosurg Psychiatry. 2016 Jun;87(6):589-97
pubmed: 26746187
Magn Reson Med. 2016 Jun;75(6):2286-94
pubmed: 26152900
Eur J Radiol. 2014 Dec;83(12):2288-2293
pubmed: 25306107
Hematol Oncol Clin North Am. 2016 Aug;30(4):867-85
pubmed: 27444001
AJNR Am J Neuroradiol. 2019 Oct;40(10):1701-1706
pubmed: 31488500
Eur Radiol. 2014 Dec;24(12):3017-24
pubmed: 25017728
Stroke Vasc Neurol. 2016 Oct 25;1(3):140-146
pubmed: 28959476
Rofo. 2017 Jul;189(7):624-631
pubmed: 28445914
J Magn Reson Imaging. 2017 Sep;46(3):751-757
pubmed: 28106936
J Stroke Cerebrovasc Dis. 2020 Sep;29(9):105062
pubmed: 32807467
Stroke. 2019 Nov;50(11):3101-3107
pubmed: 31514693
Eur Radiol. 2018 Sep;28(9):3840-3847
pubmed: 29556767
Lancet Neurol. 2009 Jul;8(7):668-78
pubmed: 19539238
Eur Radiol. 2020 Nov;30(11):5805-5814
pubmed: 32529567
Neuroradiology. 2013 May;55(5):595-602
pubmed: 23354947
Stroke. 2018 Oct;49(10):2337-2344
pubmed: 30355108
JAMA. 2018 Sep 11;320(10):1017-1026
pubmed: 30208455
AJNR Am J Neuroradiol. 2017 Feb;38(2):218-229
pubmed: 27469212
Lancet Neurol. 2015 Jun;14(6):640-54
pubmed: 25987283
JAMA Neurol. 2019 Jun 1;76(6):657-664
pubmed: 30801621
AJNR Am J Neuroradiol. 2013 Sep;34(9):E103-6
pubmed: 23064599
Magn Reson Med. 2017 Mar;77(3):1142-1150
pubmed: 26923198
Neurology. 2001 Sep 11;57(5):827-32
pubmed: 11552012